Park Yong, Ellis Dorette, Mueller Brett, Stankowska Dorota, Yorio Thomas
North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
Department of Ophthalmology, University of Louisville, Louisville, KY, USA.
Handb Exp Pharmacol. 2017;242:3-30. doi: 10.1007/164_2016_25.
Recently, in a poll by Research America, a significant number of individuals placed losing their eyesight as having the greatest impact on their lives more so than other conditions, such as limb loss or memory loss. When they were also asked to rank which is the worst disease that could happen to them, blindness was ranked first by African-Americans and second by Caucasians, Hispanics, and Asians. Therefore, understanding the mechanisms of disease progression in the eye is extremely important if we want to make a difference in people's lives. In addition, developing treatment programs for these various diseases that could affect our eyesight is also critical. One of the most effective treatments we have is in the development of specific drugs that can be used to target various components of the mechanisms that lead to ocular disease. Understanding basic principles of the pharmacology of the eye is important if one seeks to develop effective treatments. As our population ages, the incidence of devastating eye diseases increases. It has been estimated that more than 65 million people suffer from glaucoma worldwide (Quigley and Broman. Br J Ophthalmol 90:262-267, 2006). Add to this the debilitating eye diseases of age-related macular degeneration, diabetic retinopathy, and cataract, the number of people effected exceeds 100 million. This chapter focuses on ocular pharmacology with specific emphasis on basic principles and outlining where in the various ocular sites are drug targets currently in use with effective drugs but also on future drug targets.
最近,在美国研究机构开展的一项民意调查中,相当一部分人认为失明对他们生活的影响比肢体缺失或失忆等其他状况更大。当被要求对可能降临到自己身上的最严重疾病进行排序时,失明在非裔美国人中排第一,在白种人、西班牙裔和亚裔中排第二。因此,如果我们想改善人们的生活,了解眼部疾病进展机制极其重要。此外,为这些可能影响我们视力的各种疾病制定治疗方案也至关重要。我们现有的最有效治疗方法之一是研发特定药物,这些药物可用于针对导致眼部疾病机制的各个组成部分。如果想开发有效的治疗方法,了解眼部药理学的基本原理很重要。随着我们的人口老龄化,严重眼病的发病率增加。据估计,全球超过6500万人患有青光眼(奎格利和布罗曼。《英国眼科杂志》90:262 - 267,2006年)。再加上与年龄相关的黄斑变性、糖尿病视网膜病变和白内障等使人衰弱的眼病,受影响的人数超过1亿。本章重点介绍眼部药理学,特别强调基本原理,并概述目前有效药物的靶点在眼部各个部位的情况以及未来的药物靶点。